Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates (Q27469676)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates |
scientific article |
Statements
1 reference
Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates (English)
1 reference
T Tao
1 reference
B R Murphy
1 reference
M H Skiadopoulos
1 reference
F Davoodi
1 reference
J M Riggs
1 reference
P L Collins
1 reference
1 July 2000
1 reference
1 reference
6448-6458
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference